Under construction – not a live service
Sign in
Taking people in FranceNo phase

Development of Clinical and Biological Database

Key facts

Where
Montpellier, FranceSee the site

Where in France

  • Institut regional du Cancer - Val d AurelleMontpellier, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Institut du Cancer de Montpellier - Val d'Aurelle
Trial code
NCT03449264
Record updated
12 February 2025
Original description
The BCB is a tool:Read full original descriptionShow less

Development of a Monocentric and Prospective Clinical and Biological Database in Digestive Cancers, Gynecological Cancers, Breast Cancers and Sarcomas

The BCB is a tool:

* for research in analytical and public health epidemiology, biological research and for the development of data useful for clinical research and therapeutic trials; * to help scientists understand and explain phenomena ranging from the interaction of molecules to the whole metabolism of the organism in normal and pathological situations; * to identify potential strategies for prevention, diagnosis, management and analysis of cancer subtypes.

The creation of a broad clinical and biological prospective base dedicated to different types of cancer is essential for the development of such projects.

Inclusion: Age> at 18 years old,; Patient with invasive or in situ tumor pathology (proven or suspected) any stage confounded,; Patient in ICM at diagnosis; a digestive cancer (esophagus, stomach, pancreas, colon, rectum, anal canal) or; gynecological cancer (ovary, endometrium, cervix) or; breast cancer or; sarcoma; Naïve patient of any treatment for the present cancer,; Patient requiring treatment involving at least one (or more) tumor surgery (s); Patient who has accepted supplementary blood samples,; Patient having given his informed, written and express consent.

Exclusion: Patient not affiliated to a social protection scheme,; Patient whose regular follow-up is a priori impossible for psychological, familial, social or geographical reasons,; Pregnant and / or nursing women,; Subject under tutelage, curatorship or safeguard of justice,; Patient in an emergency situation.

ClinicalTrials.gov NCT03449264